Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-specific gene expression

R G Vile1

  • 1Richard Dimbleby Department of Cancer Research, St Thomas' Hospital, London, UK.

Seminars in Cancer Biology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Gene therapy for cancer requires targeted gene delivery and expression specifically in tumor cells to minimize toxicity. Strategies focus on localized delivery, dividing cell selectivity, and transcriptional regulation for safer cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.

Gene therapy·2016
Same author

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation.

Eye (London, England)·2013
Same author

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.

Oncogene·2013
Same author

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer.

Oral oncology·2012
Same author

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.

Gene therapy·2012
Same author

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.

Gene therapy·2011
Same journal

Unveiling tumor heterogeneity by single cell RNA-sequencing: from basic considerations to clinical applications.

Seminars in cancer biology·2026
Same journal

Hidden architecture of resistance: The extracellular matrix in melanoma's immune landscape.

Seminars in cancer biology·2026
Same journal

Microfluidic technologies for extracellular vesicle isolation and analysis: Implications for translational applications in cancer therapy.

Seminars in cancer biology·2026
Same journal

Exploring glioblastoma microenvironment using organoids: opportunities, limitations, and emerging concepts.

Seminars in cancer biology·2026
Same journal

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same journal

Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction.

Seminars in cancer biology·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Current cancer treatments like radio- and chemotherapy exhibit significant toxicity.
  • Gene therapy offers a promising alternative but requires precise targeting to be effective and safe.

Purpose of the Study:

  • To outline strategies for achieving tumor-specific gene expression in cancer gene therapy.
  • To ensure gene therapy is less toxic than conventional cancer treatments.

Main Methods:

  • Developing delivery vehicles with restricted tropisms to tumor cell surfaces.
  • Implementing protocols for localized gene delivery.
  • Utilizing vectors selective for dividing cells.
  • Incorporating specific transcriptional regulatory sequences.

Related Experiment Videos

Main Results:

  • Protocols have been devised to target gene expression specifically to tumor cells.
  • Minimizing gene expression in surrounding healthy cells is achievable.
  • Tumor-cell specific gene expression can be attained through combined strategies.

Conclusions:

  • Achieving tumor-specific gene expression is crucial for advancing gene therapy in oncology.
  • Combining localized delivery, cell-cycle targeting, and transcriptional control enhances safety and efficacy.
  • These approaches pave the way for realistic and less toxic cancer gene therapy modalities.